Teva Investigational Site 124 — New Bedford, Massachusetts

Teva Investigational Site 124 is a clinical research site located in New Bedford, Massachusetts, United States 02740.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Teva Investigational Site 124 has participated in 2 clinical trials.

Therapeutic areas: Chronic Migraine, Episodic Migraine Headache.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New Bedford

Browse all research sites in Massachusetts · View every site in New Bedford

• Southcoast Hospitals Group
• Southcoast Hospital
• Lucida Clinical Trials
• BTC of New Bedford
• Research Site
• Novex Clinical Research
• Teva Investigational Site 13589
• HCI Metromedic Walk-In
• Synergy Research Site
• Greater New Bedford Community Center
• GSK Investigational Site

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Investigational Site 124?

Teva Investigational Site 124 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Investigational Site 124 conducted?

Teva Investigational Site 124 has 2 clinical trials on record. Their work covers Chronic Migraine, Episodic Migraine Headache.

Is Teva Investigational Site 124 accredited by Crixeo Clinical Trials?

Teva Investigational Site 124 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Investigational Site 124?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.